Clinical feature	Statistical test	Significant genes	Associated with	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;	Associated with	
Time to Death	Cox regression test	N=3018	shorter survival	N=1360	longer survival	N=1658
AGE	Spearman correlation test	N=3682	older	N=1748	younger	N=1934
PRIMARY SITE OF DISEASE	ANOVA test	N=17315	 	 	 	 
GENDER	t test	N=8993	male	N=4112	female	N=4881
KARNOFSKY PERFORMANCE SCORE	Spearman correlation test	N=206	higher score	N=129	lower score	N=77
HISTOLOGICAL TYPE	ANOVA test	N=16971	 	 	 	 
PATHOLOGY T	Spearman correlation test	N=5911	higher pT	N=3176	lower pT	N=2735
PATHOLOGY N	Spearman correlation test	N=16	higher pN	N=3	lower pN	N=13
PATHOLOGICSPREAD(M)	ANOVA test	N=30	 	 	 	 
TUMOR STAGE	Spearman correlation test	N=7395	higher stage	N=3996	lower stage	N=3399
RADIATIONS RADIATION REGIMENINDICATION	t test	N=5814	yes	N=2865	no	N=2949
NUMBERPACKYEARSSMOKED	Spearman correlation test	N=0	 	 	 	 
TOBACCOSMOKINGHISTORYINDICATOR	ANOVA test	N=9	 	 	 	 
YEAROFTOBACCOSMOKINGONSET	Spearman correlation test	N=1	higher yearoftobaccosmokingonset	N=0	lower yearoftobaccosmokingonset	N=1
DISTANT METASTASIS	ANOVA test	N=0	 	 	 	 
LYMPH NODE METASTASIS	ANOVA test	N=2	 	 	 	 
COMPLETENESS OF RESECTION	ANOVA test	N=2319	 	 	 	 
NUMBER OF LYMPH NODES	Spearman correlation test	N=0	 	 	 	 
NEOPLASM DISEASESTAGE	ANOVA test	N=5	 	 	 	 
